C. M. Kessler

A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin

R S Schwartz, DA Gabriel, LM Aledort et al. · Blood · 1995 · 173 citations · Full text

B‐domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma‐derived factor VIII concentrate: a randomized, three‐way crossover study

C. M. Kessler, Joan Cox Gill, G C White et al. · Haemophilia · 2005 · 55 citations

Factor <scp>VIII</scp> alloantibody inhibitors: cost analysis of immune tolerance induction vs. prophylaxis and on‐demand with bypass treatment

Stephanie Earnshaw, Christopher N. Graham, Cheryl McDade et al. · Haemophilia · 2015 · 53 citations · Full text

High Titre Inhibitors, Bypass Treatment, Lifetime Costs +25

ReFacto®¹ and Advate®²: a single‐dose, randomized, two‐period crossover pharmacokinetics study in subjects with haemophilia A

Jorge Di Paola, Mark P. Smith, Robert Klamroth et al. · Haemophilia · 2007 · 50 citations

Collagen-factor VIII/von Willebrand factor protein interaction

C. M. Kessler, CM Floyd, ME Rick et al. · Blood · 1984 · 38 citations · Full text